European Federation of Biotechnology

The European Federation of Biotechnology (EFB) is a nonprofit professional federation established in 1978 by European scientists to support the responsible development and application of biotechnology. Rather than operating as a commercial biotechnology company, the EFB functions as a convening, educational, scientific, and public-dialogue organization. Its membership base brings together national biotechnology associations, learned societies, universities, research institutes, biotechnology companies, and individual biotechnologists. The federation's central purpose is to encourage the safe, sustainable, and beneficial use of life sciences. Its activities span scientific research, industrial innovation, education, interdisciplinary cooperation, and communication with the public. In this role, the EFB provides a network through which academic researchers, industrial specialists, policymakers, students, and other stakeholders can exchange knowledge across national and disciplinary boundaries. Its stated scope covers biotechnology broadly, including biological production systems, bioprocessing, biopharmaceuticals, environmental applications, agricultural and food biotechnology, and related areas of bioeconomy development. The EFB is organized around seven specialist divisions: Biobased Materials; Biocatalysis; Bioengineering and Bioprocessing; Biopharmaceutical; Environmental Biotechnology; Microbial Biotechnology; and Plant, Agriculture and Food. These divisions provide subject-focused communities within the wider federation and support specialist meetings, scientific exchange, and collaboration. The organization has reported more than 25,000 individual members, indicating a substantial professional network across Europe and associated international communities. A major part of the EFB's public profile is its conference program. The European Congress on Biotechnology, inaugurated in 1978 in Interlaken, Switzerland, is organized by the federation as a meeting point for academic and industrial biotechnologists and is held every two years. The EFB and its divisions also organize specialist events covering applied synthetic biology, recombinant protein production, bioeconomy-related themes, microbial stress, and the physiology of yeasts and filamentous fungi. Publishing is another important activity. New Biotechnology serves as the federation's official peer-reviewed journal and has been issued by Elsevier on a bimonthly basis since 2008. The EFB also publishes the open-access EFB Bioeconomy Journal, which addresses research and policy questions connected with the bioeconomy. Through these publications, the federation supports the circulation of research findings and discussion of the wider social, industrial, and policy implications of biotechnology. The EFB Central Office is located in Barcelona, Spain. Its positioning is that of a cross-sector European scientific federation rather than a product brand: it builds networks, supports specialist communities, organizes congresses and conferences, publishes research, and promotes informed discussion about biotechnology. The federation's work is relevant to both fundamental and applied life sciences, while its mission emphasizes responsible innovation and communication between scientists, industry, and the public.

The European Federation of Biotechnology was established in 1978 by European scientists who sought to create a broad professional framework for cooperation in biotechnology. The federation's inauguration was associated with the first European Congress on Biotechnology, held in Interlaken, Switzerland, in the same year. From its beginning, the EFB was structured as a federation rather than as a single research institute or commercial enterprise. Its constituency included national biotechnology associations, learned societies, universities, scientific institutes, biotechnology companies, and individual practitioners. The federation developed around the idea that biotechnology required cooperation across scientific disciplines and across the boundaries separating academia, industry, government, and the public. Its mission therefore extended beyond the dissemination of research. The EFB aimed to encourage the safe and sustainable use of life sciences, support innovative research, improve scientific education, and provide forums in which technical and societal questions could be discussed. This broad mandate allowed the organization to address both emerging research fields and established industrial applications. Over time, the EFB organized its professional activity through specialist divisions. The seven divisions cover biobased materials, biocatalysis, bioengineering and bioprocessing, biopharmaceuticals, environmental biotechnology, microbial biotechnology, and plant, agriculture and food biotechnology. Together, these divisions reflect the breadth of the biotechnology field, from biological manufacturing and industrial catalysis to healthcare, environmental protection, food systems, and agricultural applications. They also give members opportunities to participate in more focused scientific communities within the larger European federation. The European Congress on Biotechnology became a continuing platform for the organization. Held every second year, the congress brings together academic and industrial biotechnologists and provides a setting for research presentations, professional exchange, and discussion of developments affecting the field. Alongside the congress, the EFB and its divisions established specialized events. These have included Applied Synthetic Biology in Europe, Recombinant Protein Production, the Green for Good series, Microbial Stress, and the Conference on the Physiology of Yeasts and Filamentous Fungi. The event portfolio demonstrates the federation's preference for combining broad federation-wide meetings with technically focused forums. Publishing became another durable component of the EFB's work. New Biotechnology is the federation's official peer-reviewed journal and has been published by Elsevier every two months since 2008. The journal provides a formal outlet for biotechnology research and related scientific discussion. The federation also publishes the open-access EFB Bioeconomy Journal, which addresses research and policy issues associated with the bioeconomy. This publishing activity extends the EFB's role beyond in-person meetings and supports the continuing exchange of scientific and policy knowledge. The EFB has reported a network of more than 25,000 individual members. Its Central Office is located in Barcelona, Spain, while its activities and membership are European in scope and extend beyond Europe. In its mature form, the federation operates as a platform for networking, education, publication, scientific events, and informed public dialogue. It does not present itself as a biotechnology manufacturer with proprietary product lines; its principal outputs are communities, knowledge, professional events, and communication channels supporting responsible biotechnology development.

1. 2008New Biotechnology becomes the official journal

   New Biotechnology began its identified period as the EFB's official peer-reviewed journal, published bimonthly by Elsevier.

   Source
2. 1978Federation established

   European scientists established the European Federation of Biotechnology as a nonprofit federation for cooperation among biotechnology organizations, institutions, companies, and professionals.

   Source
3. 1978First European Congress on Biotechnology

   The inaugural European Congress on Biotechnology took place in Interlaken, Switzerland, and marked the beginning of the federation's continuing congress program.

   Source

A nonprofit European scientific and professional federation that connects biotechnology research, industry, education, and public dialogue.

• European Congress on BiotechnologyScientific congress1978

  The EFB's principal recurring congress for academic and industrial biotechnologists. It was inaugurated in 1978 and is held every two years, providing a broad forum for scientific presentations, professional networking, and discussion of developments across biotechnology.

• New BiotechnologyPeer-reviewed journal2008

  The federation's official peer-reviewed scientific journal. It has been published by Elsevier on a bimonthly schedule since 2008 and serves as a publication channel for biotechnology research and related scientific analysis.

• EFB Bioeconomy JournalOpen-access journal

  An open-access publication associated with the EFB that covers research and policy issues concerning the bioeconomy. It extends the federation's work into questions involving biotechnology, sustainability, economic development, and public policy.

• Specialist biotechnology eventsProfessional events

  The EFB and its specialist divisions organize focused events in areas including applied synthetic biology, recombinant protein production, bioeconomy applications, microbial stress, and the physiology of yeasts and filamentous fungi.

1. European Federation of Biotechnology
2. European Federation of Biotechnology official website